Innate Pharma S.A. (IPHA)
NASDAQ: IPHA · Real-Time Price · USD
1.840
-0.070 (-3.66%)
Jun 27, 2025, 4:00 PM - Market closed
Innate Pharma Market Cap
Innate Pharma has a market cap or net worth of $176.63 million as of June 27, 2025. Its market cap has decreased by -1.38% in one year.
Market Cap
176.63M
Enterprise Value
119.30M
1-Year Change
-1.38%
Ranking
Category
Stock Price
$1.84
Market Cap Chart
Since April 25, 2013, Innate Pharma's market cap has increased from $125.22M to $176.63M, an increase of 41.06%. That is a compound annual growth rate of 2.87%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 700.13B |
| Johnson & Johnson | 367.00B |
| AbbVie | 326.78B |
| Novo Nordisk | 299.93B |
| UnitedHealth Group | 278.90B |
| Novartis AG | 235.02B |
| Abbott Laboratories | 233.12B |
| AstraZeneca | 215.99B |